As our industry evolves through new regulations, demographic shifts, and advancing technology, innovation and leadership that embraces diverse perspectives becomes increasingly vital....
Patient advocate Christine Von Raesfeld says patient burden should join trial metrics such as cost and regulatory compliance....
Leveraging artificial intelligence could help drug developers more efficiently screen chemical libraries to identify the few chemicals most likely to affect their research targets....
The Association of Clinical Research Professionals (ACRP) has released comprehensive findings from the first-ever workforce survey focused on the evolution of the clinical research enterprise....
The first hints that Gregory Nelson might be having cognitive troubles were subtle. So subtle, in fact, that his doctor assured him nothing was wrong....
As one efficacy guideline among others created by the ICH, E6(R3) is more than just a technical update. It represents a paradigm shift in how clinical trials are designed, conducted, and overseen....
Nura Said discusses her career path and current role as Regulatory Coordinator within the UW Clinical Trials Institute....
An associate professor at the University of Wisconsin-Madison is leading a clinical trial on whether over-the-counter hearing aids are actually beneficial to listeners with changings to their memory skills and thinking....
Scientists at UW-Madison are leading national studies on psilocybin, to determine whether the psychedelic compound could offer lasting relief for mental health and substance use disorders....
In labs and clinical trials in Madison, doctors are increasingly using patients' own immune systems to attack and kill cancer cells that have cleverly evaded radiation and chemotherapy....
